Received Nov 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (MODERNA BIVALENT)) | MODERNA | 5 | — | — |
Soreness in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the left arm) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer (1st dose) in 2021, Pfizer (2nd dose, 3 weeks later another Pfizer) in 2021 and Pfizer (3rd dose) in September 2021. Past adverse reactions to the above products included No adverse effect with Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Asthma and Blood pressure high. On 04-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in the left arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the left arm) outcome was unknown. No concomitant medication was reported. It was reported that she had soreness in the left arm than experienced with COVID-19 vaccines. No treatment information was reported. This case was linked to MOD-2025-790544 (Patient Link).
Asthma; Blood pressure high